ginsenoside rh2 has been researched along with Osteogenic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, C; Feng, X; Gao, H; Li, C; Yin, J; Zhang, J | 1 |
| Cai, X; Han, B; Lan, X; Liu, D; Mao, X; Tu, S; Wang, H; Ye, Z; Zhang, Y; Zhang, Z; Zhou, Z; Zuo, G | 1 |
2 other study(ies) available for ginsenoside rh2 and Osteogenic Sarcoma
| Article | Year |
|---|---|
Ginsenoside Rh2 impedes proliferation and migration and induces apoptosis by regulating NF-κB, MAPK, and PI3K/Akt/mTOR signaling pathways in osteosarcoma cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Ginsenosides; Humans; In Situ Nick-End Labeling; Membrane Potential, Mitochondrial; Mitogen-Activated Protein Kinases; NF-kappa B; Osteosarcoma; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |
Integrated bioinformatic analysis and experiment confirmation of the antagonistic effect and molecular mechanism of ginsenoside Rh2 in metastatic osteosarcoma.
Topics: Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Computational Biology; Ginsenosides; Humans; Osteosarcoma; Phosphatidylinositol 3-Kinases | 2021 |